PYRIMETHAMINE AS A POTENTIAL PHARMACOLOGICAL CHAPERONE FOR LATE-ONSET FORMS OF GM2 GANGLIOSIDOSIS

Podobne zapisy

• The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
  od: Maegawa, Gustavo H. B., i wsp.
  Wydane: (2006)
• An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
  od: Clarke, Joe T.R., i wsp.
  Wydane: (2010)
• Crystal Structure of β-Hexosaminidase B in Complex with Pyrimethamine, a Potential Pharmacological Chaperone()
  od: Bateman, Katherine S., i wsp.
  Wydane: (2011)
• Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
  od: Rigat, Brigitte A., i wsp.
  Wydane: (2012)
• Lending a helping hand, screening chemical libraries for compounds that enhance β-hexosaminidase A activity in GM2 gangliosidosis cells
  od: Tropak, Michael B., i wsp.
  Wydane: (2007)